Trisalus Life Sciences, Inc. · NASDAQ:TLSI
Frankenius Equity AB converted 759,000 Trisalus Life Sciences, Inc. shares (Form 4)
Traded Jul 31, 2025 · Filed Apr 20, 2026
On Jul 31, 2025, Frankenius Equity AB (10% owner) converted 759,000 Trisalus Life Sciences, Inc. shares, leaving 6,989,748 shares. Filed Apr 20, 2026 (Form 4).
- Converted
- 759,000 shares
- Holding after
- 6,989,748 shares
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 31, 2025 | Common Stock | Conversion | 759,000 | 6,989,748 | Direct |
Source
Related
- Trisalus Life Sciences, Inc.
- Frankenius Equity AB
- Trisalus Life Sciences, Inc. shareholders
- Form 4 · Cox Bryan F. · Oct 7, 2026
- Form 4 · Marshak Richard · Oct 7, 2026
- Form 4 · Stevens Jennifer · Oct 7, 2026
- Form 4 · Szela Mary T · Oct 7, 2026
- Schedule 13G/A · First Light Asset Management, LLC · Jul 7, 2026